1. Home
  2. AUB vs KYMR Comparison

AUB vs KYMR Comparison

Compare AUB & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$34.82

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$86.72

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUB
KYMR
Founded
1902
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
4.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AUB
KYMR
Price
$34.82
$86.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
19
Target Price
$39.93
$69.58
AVG Volume (30 Days)
1.0M
1.0M
Earning Date
01-22-2026
11-04-2025
Dividend Yield
4.30%
N/A
EPS Growth
N/A
N/A
EPS
1.75
N/A
Revenue
$1,048,582,000.00
$43,735,000.00
Revenue This Year
$79.19
$20.81
Revenue Next Year
$14.11
N/A
P/E Ratio
$19.62
N/A
Revenue Growth
41.48
N/A
52 Week Low
$22.85
$19.45
52 Week High
$43.12
$103.00

Technical Indicators

Market Signals
Indicator
AUB
KYMR
Relative Strength Index (RSI) 58.73 72.75
Support Level $33.94 $64.84
Resistance Level $34.95 $103.00
Average True Range (ATR) 0.88 4.10
MACD 0.23 2.09
Stochastic Oscillator 89.92 59.15

Price Performance

Historical Comparison
AUB
KYMR

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: